Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections
Fig 7
Lead compound (left side) and three complexes of three-dimensional chemical interactions (right side) obtained from molecular docking. (a) AURKA vs. Nilotinib, (b) AURKB vs. Tegobuvir, and (c) OAS1 vs. Proscillaridin.